Dr. Reddy’s Renames Injectables Research Unit
By

Dr. Reddy’s Laboratories, a Hyderabad, India-headquartered integrated pharmaceutical company, has renamed Octoplus, its Leiden, Netherlands-based research center, and affiliated legal entities of OctoPlus to Dr. Reddy’s Research and Development B.V., effective immediately.

OctoPlus, which develops long-acting injectables and liposomal pharmaceutical formulations, was acquired by Dr. Reddy’s in 2013 and became a fully integrated Center of Excellence for the development of Dr. Reddy’s complex injectables. The renaming of the entity to the Dr. Reddy’s name reflects Dr. Reddy’s strategy of transforming the entity from an external service provider to an integrated research and development (R&D) center, now one of two R&D centers based in Europe. Dr. Reddy’s Research and Development B.V. is currently focusing all its efforts on internal projects.

Source: Dr. Reddy’s Laboratories

Leave a Reply

Your email address will not be published. Required fields are marked *